Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
08/29/2002 | WO2000061606A9 Novel human voltage-gated potassium channel |
08/29/2002 | WO2000034475A9 Grnf4, a gdnf-related neurotrophic factor |
08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
08/29/2002 | US20020120947 Protein-protein interactions in neurodegenerative disorders |
08/29/2002 | US20020120149 Substituted hydrazine derivatives |
08/29/2002 | US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them |
08/29/2002 | US20020120103 17 human secreted proteins |
08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
08/29/2002 | US20020120005 Method for the preparation of pure citalopram |
08/29/2002 | US20020120003 Methods for decreasing beta amyloid protein |
08/29/2002 | US20020119993 Nervous system disorders |
08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
08/29/2002 | US20020119987 Analgesics, anesthetic; side effect reduction |
08/29/2002 | US20020119983 Novel isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
08/29/2002 | US20020119975 Autoimmune disease; antiinflammatory agents; antiallergens; antiproliferative agents; anticancer agents |
08/29/2002 | US20020119973 Antiinflammatory agents |
08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
08/29/2002 | US20020119966 Central nervous system disorders |
08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
08/29/2002 | US20020119963 Fertility; antidiabetic agents |
08/29/2002 | US20020119961 Bridged piperazine derivatives |
08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
08/29/2002 | US20020119923 Administering macrophage derived compound |
08/29/2002 | US20020119912 Synergistic mixture; therapy for psychological disorders |
08/29/2002 | US20020119479 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant GPIIb allele |
08/29/2002 | US20020119206 Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions |
08/29/2002 | US20020119191 Pharmaceutical or food composition for treatment or prevention of brain edema |
08/29/2002 | US20020119186 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
08/29/2002 | US20020119164 Use of agaricus blazei murill to prevent or treat skin and other disorders |
08/29/2002 | US20020119143 Antithrombin III for disorders caused by angiogenesis |
08/29/2002 | DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives |
08/29/2002 | DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
08/29/2002 | DE10106971A1 Arzneimittelformulierung die einen muskarinischen Agonisten enthält Pharmaceutical formulation containing a muscarinic agonist |
08/29/2002 | DE10065478C1 Kreatin/Citronensäure-Verbindung, Verfahren zu ihrer Herstellung und Verwendung Creatine / citric acid combination, processes for their preparation and use |
08/29/2002 | CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy |
08/29/2002 | CA2439898A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
08/29/2002 | CA2439193A1 Casoase 3 inhibitors |
08/29/2002 | CA2438805A1 Fluoro oxindole derivatives as modulators of kcnq potassium channels |
08/29/2002 | CA2438711A1 Tryptase inhibitors |
08/29/2002 | CA2438685A1 Tryptase inhibitors |
08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
08/29/2002 | CA2438650A1 Process for the preparation of citalopram |
08/29/2002 | CA2438519A1 Emulsions and aqueous dispersions of phytosterols |
08/29/2002 | CA2438518A1 Method of treating neurological diseases |
08/29/2002 | CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
08/29/2002 | CA2438367A1 Thiophene substituted amine derivatives as glyt-1 inhibitors |
08/29/2002 | CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
08/29/2002 | CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
08/29/2002 | CA2438312A1 Anthrone derivatives and their use as jnk inhibitors |
08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
08/29/2002 | CA2438241A1 Medicinal compositions comprising diclofenac and ornoprostil |
08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
08/29/2002 | CA2438231A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
08/29/2002 | CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases |
08/29/2002 | CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
08/29/2002 | CA2437242A1 Tramadol-based medicament |
08/29/2002 | CA2435177A1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
08/29/2002 | CA2434648A1 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
08/29/2002 | CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
08/29/2002 | CA2433348A1 Detection of compounds that modulate inflammatory responses |
08/29/2002 | CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
08/29/2002 | CA2411973A1 New phenylpiperazines |
08/28/2002 | EP1234828A1 Agents for improving learning or memory |
08/28/2002 | EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
08/28/2002 | EP1234816A1 Scyphostatin analogues as SMase inhibitors |
08/28/2002 | EP1234055A2 Genetic indicators of tobacco consumption |
08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
08/28/2002 | EP1234041A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
08/28/2002 | EP1233975A1 29 human secreted proteins |
08/28/2002 | EP1233973A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
08/28/2002 | EP1233966A1 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
08/28/2002 | EP1233965A1 Isoquinoline and quinazoline derivatives for the treatment of cns disorders |
08/28/2002 | EP1233964A1 New use and novel n-azabicyclo-amide derivatives |
08/28/2002 | EP1233963A2 Novel sulfonyl oxazole amines |
08/28/2002 | EP1233962A2 Novel heterocyclic compounds and their use as medicines |
08/28/2002 | EP1233960A2 Polymorphic salt of an anti-migraine drug |
08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
08/28/2002 | EP1233957A1 Novel amidine derivatives, preparation and use thereof as medicines |
08/28/2002 | EP1233953A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
08/28/2002 | EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
08/28/2002 | EP1233949A2 5-substituted arylpyrimidines |
08/28/2002 | EP1233945A1 Heterocyclic ketone and thioester compounds and uses |
08/28/2002 | EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
08/28/2002 | EP1233778A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
08/28/2002 | EP1233776A1 Urotensin-ii cyclic analogs |
08/28/2002 | EP1233774A1 Urotensin-ii analogs |
08/28/2002 | EP1233773A1 Mixture of pomegranate seed oil and juice products |
08/28/2002 | EP1233769A1 Novel compounds |
08/28/2002 | EP1233766A1 Use of synergistic combinations of a nk 1? receptor antagonist and a gaba analog in psychiatric disorders |
08/28/2002 | EP1233758A2 Cassette-shaped constructional units in a rotary printing machine |
08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
08/28/2002 | EP1233670A1 Nitric oxide donors for inducing neurogenesis |